Studying Side Effects & Best Treatment for Pts w/Liver Tumors

Treatment of Children with All Stages of Hepatoblastoma.

November 22, 2017

  • Clinical Trial Information

    Trial Contact: El-Shami, Jessica

    Trial Phone: 321.841.3837

  • IRB No: AHEP0731

    Principal Investigator: Vincent F. Giusti, MD

    Sub Investigators: AguilarBonilla, Ana MD; Eslin, Don MD; Gray, Rachel PA-C; Kelly, Susan MD; Martin, Rebecca, ARNP; Pope, Michele ARNP; Smith, Amy MD; Story, Allison ARNP; Sullivan, Kelly ARNP; Sutphin, Robert MD; Wieber, Laura ARNP; Levy, Alejandro MD

    Phase: Drug: Phase III

    Age Group: Pediatric

    Secondary Protocol No: AHEP0731

    Treatment: Surgery; Radiation

    Applicable Disease Sites: Liver

    Therapies Involved: Procedure: Surgery Drug: Chemotherapy (multiple) Procedure: Liver Transplantation Other: Laboratory Biomarker Analysis

    ClinicalTrials.gov ID: NCT00980460

  • Objective

    This trial studies the side effects and how well risk-based therapy works in treating younger patients with newly diagnosed liver cancer.

  • Key Eligibility

    Ages Eligible for Study: up to 21 Years; Genders Eligible for Study: Both; Accepts Healthy Volunteers: No